Table 2.

Summary of reported cases of retinal vein occlusion occurring after COVID-19 vaccination.

Publication Date	Diagnosis	Age	Sex	Risk factor	Vaccine	Onset of Symptoms After Vaccine
August 23, 202127	CRVO with CME	50	Male	None	Pfizer	15 minutes
September 25, 202130	Non-ischemic CRVO	52	Male	None	Pfizer	14 days
November 17, 202119	Combined BRAO and BRVO	81	Female	Hypertension	Pfizer	12 days
December 5, 202128	RVO	68	Female	None	AstraZeneca	1 day
December 5, 202128	RVO	76	Male	Hypertension	Pfizer	3 days
December 5, 202128	RVO	85	Female	Diabetes mellitus, hypertension	Pfizer	1 day
December 5, 202128	RVO	59	Male	Diabetes mellitus, hypertension	AstraZeneca	2 days
December 5, 202128	RVO	61	Male	None	AstraZeneca	2 days
December 5, 202128	RVO	79	Male	Diabetes mellitus	Pfizer	2 days
December 5, 202128	RVO	77	Female	Hypertension	Pfizer	16 days
December 5, 202128	RVO	63	Male	Diabetes mellitus	Pfizer	13 days
December 5, 202128	RVO	51	Female	Hypertension	AstraZeneca	21 days
December 5, 202128	RVO	81	Female	Hypertension	Pfizer	4 days
December 5, 202128	RVO	61	Male	Hypertension	AstraZeneca	3 days
December 9, 202129	HRVO with CME	74	Female	None	Moderna	2 days
January 9, 202231	Combined CRAO and CRVO	54	Female	None	Moderna	2 days
January 1, 202232	CRVO with CME	50	Male	Diabetes mellitus	AstraZeneca	4 days
January 1, 202232	CRVO without CME	43	Female	None	AstraZeneca	3 days
February 3, 202233	BRVO with CME	71	Male	None	AstraZeneca	2 days
February 3, 202233	HRVO with CME	58	Male	None	AstraZeneca	3 days
February 3, 202233	BRVO with CME	73	Female	Hypertension	AstraZeneca	3 days
February 3, 202233	BRVO with CME	47	Female	None (Hyperthyroidism on treatment)	Pfizer	5 days
February 3, 202233	Non-ischemic CRVO with CME	36	Male	None	Pfizer	1–3 days